MDNC

Medinotec Inc. Stock Price

OTCPK:MDNC Community·US$58.7m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

MDNC Share Price Performance

US$5.00
0.00 (0.00%)
US$5.00
0.00 (0.00%)
Price US$5.00

MDNC Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet and fair value.

3 Risks
2 Rewards

Medinotec Inc. Key Details

US$9.1m

Revenue

US$4.3m

Cost of Revenue

US$4.9m

Gross Profit

US$2.7m

Other Expenses

US$2.2m

Earnings

Last Reported Earnings
Feb 28, 2025
Next Reporting Earnings
n/a
0.18
53.34%
23.70%
22.0%
View Full Analysis

About MDNC

Founded
2021
Employees
37
CEO
Gregory Vizirgianakis
WebsiteView website
www.medinotecinc.com

Medinotec Inc. engages in the research and development, production, and sale of medical devices for the treatment of vascular and airway diseases in South Africa, the United States, and internationally. The company offers semi-compliant percutaneous transluminal coronary angioplasty balloon catheters, suction dissectors, aortic perfusion and dilation catheters, chronic total occlusion catheters, and silicone tracheal stents. It serves hospitals, clinics, third-party healthcare providers, distributors, and other institutions, including governmental healthcare programs and group purchasing organizations. The company sells its products through the network of distributors and direct sales force. Medinotec Inc. was incorporated in 2021 and is headquartered in Johannesburg, South Africa.

Recent MDNC News & Updates

Recent updates

No updates